GlaxoSmithKline (GSK)
is committed to improving the quality of human life by enabling
people to do more, feel better and live longer. We pursue this mission not only through the
medicines and vaccines we develop and make available but also through a wide variety of community
support initiatives. GSK invests in health and education programmes and partnerships that aim to
bring sustainable improvements to under-served people in the developed and developing world.
Merck & Co., Inc. is
a global research-driven pharmaceutical company dedicated to putting
patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines
and medicines to address unmet medical needs. The company devotes extensive efforts to increase
access to medicines through far-reaching programs that not only donate Merck medicines but help
deliver them to the people who need them. Merck also publishes unbiased health information as a
not-for-profit service.
The Pharmaceutical Research
and Manufacturers of America (PhRMA) represents the country's
leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines
that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading
the way in the search for new cures. PhRMA members alone invested an estimated $39.4 billion in 2005
in discovering and developing new medicines. Industry wide research and investment reached a record
$51.3 billion in 2005. www.phrma.com
Quintiles is the
worldwide leader in clinical research. With offices in more than 50
countries including those in non-traditional regions such as Africa, India, Asia, and Latin America,
Quintiles has what it takes to get complex global trials up and running quickly, and keep things
moving straight through to completion. We have extensive experience in infectious diseases,
including HIV and AIDS-related diseases, malaria, hookworm, and many other areas. Through our
Public Health Development Services, our proposal and contracting functions are well versed in Federal
Acquisition Regulations and the flow-down impact of FARs into how we deliver and report our projects.
Sanofi-Aventis is the
world's third largest pharmaceutical company, ranking number one in
Europe. Backed by a world-class R&D organization, Sanofi-Aventis is developing leading positions in
seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central
nervous system, internal medicine and vaccines.
GlaxoSmithKline (GSK)
is committed to improving the quality of human life by enabling
people to do more, feel better and live longer. We pursue this mission not only through the
medicines and vaccines we develop and make available but also through a wide variety of community
support initiatives. GSK invests in health and education programmes and partnerships that aim to
bring sustainable improvements to under-served people in the developed and developing world.
Merck & Co., Inc. is
a global research-driven pharmaceutical company dedicated to putting
patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines
and medicines to address unmet medical needs. The company devotes extensive efforts to increase
access to medicines through far-reaching programs that not only donate Merck medicines but help
deliver them to the people who need them. Merck also publishes unbiased health information as a
not-for-profit service. 
The Pharmaceutical Research
and Manufacturers of America (PhRMA) represents the country's
leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines
that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading
the way in the search for new cures. PhRMA members alone invested an estimated $39.4 billion in 2005
in discovering and developing new medicines. Industry wide research and investment reached a record
$51.3 billion in 2005. www.phrma.com
Quintiles is the
worldwide leader in clinical research. With offices in more than 50
countries including those in non-traditional regions such as Africa, India, Asia, and Latin America,
Quintiles has what it takes to get complex global trials up and running quickly, and keep things
moving straight through to completion. We have extensive experience in infectious diseases,
including HIV and AIDS-related diseases, malaria, hookworm, and many other areas. Through our
Public Health Development Services, our proposal and contracting functions are well versed in Federal
Acquisition Regulations and the flow-down impact of FARs into how we deliver and report our projects. 
Sanofi-Aventis is the
world's third largest pharmaceutical company, ranking number one in
Europe. Backed by a world-class R&D organization, Sanofi-Aventis is developing leading positions in
seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central
nervous system, internal medicine and vaccines.